FDA clears Sanofi's Nasacort for OTC use

Sanofi announced Friday that the FDA has granted its allergy spray Nasacort approval to be sold over the counter in drugstores. The medication, which was approved to treat adults and children 2 and older with allergies, was the first steroid nasal spray to attain clearance for OTC use.

View Full Article in:

Wall Street Journal (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
President/Chief Executive Officer
MedCost
Winston-Salem, NC
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA
Director, Payer Marketing
Avalere Health
Washington, DC
Actuary
Meridian Health Plan
Detroit, MI
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Childre's Health Plan
Houston, TX